📦 At-home sample collection kits now available. Fast 1-day AI video microscopy findings —Order your kit →

    Post-Vaccination Syndrome

    What published research says about post-vaccination syndrome, spike-driven fibrin microclots, its overlap with Long COVID and the limits of the evidence.

    Start with these guides

    Fluorescence microscopy style illustration of amyloid-positive microclot deposits in plasma
    Research
    Review

    Post-Vaccination Microclots: What the Spike-Fibrin Research Shows

    What research says about microclots after mRNA vaccination: the shared spike sequence argument, the PV/PIS cohort findings, and where the evidence stops.

    Tim OttowitzApr 22, 2026
    8m
    Illustration of fibrin strands forming a blood clot, the protein network that can misfold into amyloid microclots
    Guide

    Amyloid Fibrin Test: How Fibrin Amyloid Microclots Are Detected

    What an amyloid fibrin test is, how Thioflavin T microscopy spots fibrin amyloid microclots, how it differs from D-dimer, and what it can't tell you.

    Tim OttowitzOct 15, 2026
    12m

    All post-vaccination syndrome articles

    Abstract illustration of pale blue branching fibrils against a light background
    Research
    Review

    COVID Vaccine Harms: What the 2025 JPandS Review Argues

    A plain-language walkthrough of the 2025 JPandS review on COVID vaccine harms: what it claims, which sources hold up, and where the evidence is weak.

    Tim OttowitzSep 22, 2026
    8m
    Laboratory scientist preparing plasma samples for mass spectrometry analysis
    Resource
    Observational

    Spike Protein Antibody vs Antigen Testing: What Each One Measures

    Spike antibody tests measure immune memory, not spike protein. What antigen testing adds, why detox protocols stall, and what a serious panel includes.

    Tim OttowitzApr 30, 2026
    8m
    Lab scientist in protective gear holding a sample tube beside lab analyzers and a microscope
    Research
    Preclinical

    Protein Nanoparticles for mRNA Delivery: A Lipid-Free Alternative

    How a Harvard team built ENTER, a lipid-free protein nanoparticle that carried mRNA, CRISPR and siRNA in cells and mice, and what the data can't show.

    Tim OttowitzApr 30, 2026
    14m
    AmyloidTest

    At-home amyloid screening with a dedicated treatment path after results. Start with the kit, review your findings, and then move into treatment planning if appropriate.

    Amyloid Screening Support

    [email protected]

    Worldwide sample collection and physician-directed follow-up support.

    Screening is informational and helps determine whether the treatment path should be explored.

    This service provides informational laboratory screening only. It is not a diagnosis and does not guarantee treatment candidacy.

    Treatment decisions, if any, happen only after results review and clinical assessment.

    © 2026 AmyloidTest. All Rights Reserved.